Nektar Therapeutics (NKTR) Posts Q3 Loss of $0.21, Sales Top Expectations
Go back to Nektar Therapeutics (NKTR) Posts Q3 Loss of $0.21, Sales Top Expectations| Nektar Therapeutics (NASDAQ: NKTR) | Delayed: 66.69 --0 (-0%) | |||||
|---|---|---|---|---|---|---|
| Previous Close | $66.69 | 52 Week High | $19.98 | |||
| Open | $66.69 | 52 Week Low | $10.52 | |||
| Day High | $66.69 | P/E | N/A | |||
| Day Low | $66.69 | EPS | $-1.45 | |||
| Volume | 200 | |||||
